Use of 4-androstene-3,6,17-trione to elevate testosterone levels and the testosterone/estrogen ratio in males
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Mar 17, 2005
app pub date -
Sep 15, 2003
filing date -
Sep 15, 2003
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
The present invention involves the use of 4-androstene-3,6,17-trione to stimulate endogenous testosterone production in males, while leaving estrogen levels relatively unaffected. It also involves the use of 4-androstene-3,6,17-trione to increase the testosterone/estrogen (T/E) ratio in males.
Loading the Abstract Image...
OK
First Claim
Family
Loading Family data...
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully